These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2015615)

  • 1. Spinal myoclonus: successful treatment with the combination of sodium valproate and L-5-hydroxytryptophan.
    Jiménez-Jiménez FJ; Roldan A; Zancada F; Molina-Arjona JA; Fernandez-Ballesteros A; Santos J
    Clin Neuropharmacol; 1991 Apr; 14(2):186-90. PubMed ID: 2015615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 3. L-5-hydroxytryptophan therapy in myoclonus.
    Van Woert MH; Rosenbaum D
    Adv Neurol; 1979; 26():107-15. PubMed ID: 316273
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
    Gascon G; Wallenberg B; Daif AK; Ozand P
    Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants.
    Gobbi G; Melideo G; Giovanardi Rossi P
    Neuropediatrics; 1986 May; 17(2):63-5. PubMed ID: 3014368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy].
    Lhermitte F; Degos CF; Marteau R
    Nouv Presse Med; 1975 Jan; 4(1):31. PubMed ID: 1079935
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanisms of action of valproic acid in myoclonus.
    Van Woert MH; Chung EY
    Adv Neurol; 1986; 43():653-60. PubMed ID: 2418654
    [No Abstract]   [Full Text] [Related]  

  • 11. L-5-hydroxytryptophan therapy in myoclonus: discussion.
    Adv Neurol; 1979; 26():117-22. PubMed ID: 316274
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
    Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K
    Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 14. Spinal myoclonus resembling belly dance.
    Kono I; Ueda Y; Araki K; Nakajima K; Shibasaki H
    Mov Disord; 1994 May; 9(3):325-9. PubMed ID: 8041373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palatal myoclonus: treatment with 5-hydroxytryptophan and carbidopa.
    Bhatt M; Snow B; Varelas M; Calne D
    Mov Disord; 1990; 5(4):339-40. PubMed ID: 2259361
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate and myoclonus.
    Chapman AG
    Adv Neurol; 1986; 43():661-74. PubMed ID: 3080855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated continuous rhythmic lingual myoclonus.
    Gobernado JM; Galarreta M; De Blas G; Jimenez-Escrig A; Hernandez A
    Mov Disord; 1992 Oct; 7(4):367-9. PubMed ID: 1484534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
    Growdon JH; Young RR; Shahani BT
    Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lance-Adams syndrome in patient with anoxic encephalopathy in the course of bronchial asthma].
    Kowalczyk EE; Koszewicz MA; Budrewicz SP; Podemski R; Słotwiński K
    Wiad Lek; 2006; 59(7-8):560-2. PubMed ID: 17209360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry and therapeutics of posthypoxic myoclonus.
    Van Woert MH; Rosenbaum D; Chung EY
    Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.